Skip to Content

'
Naifa L. Busaidy, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1997 Baylor College of Medicine, Houston, TX, MD, Internal Medicine
1993 Houston Baptist University, Houston, TX, BS, Biology and Psychology

Postgraduate Training

10/2005-2/2006 Student Clinical & Effectiveness Course, University of Texas MD Anderson Cancer Center, Houston, TX
7/2003-6/2004 Research Fellow Department of Endocrine Neoplasia & Hormonal Disorders, UT M. D. Anderson Cancer Center, Houston, TX, Steven Sherman
7/2001-6/2003 Fellow Division of Diabetes, Endocrinology and Metabolism, Baylor College of Medicine/UT M. D. Anderson Cancer Center, Houston, TX
7/1998-6/2001 Resident Internal Medicine, Baylor College of Medicine, Houston, TX
9/1997-5/1998 Transitional Intern, The Royal Hospital and the Sultan Qaboos University Hospital, Sultanate Of Oman

Board Certifications

1/2003 American Board of Internal Medicine, Endocrinology
1/2001 American Board of Internal Medicine

Selected Publications

Peer-Reviewed Original Research Articles
1. Perrier N, Busaidy N,. Preoperative Vitamin D replacement therapy in primary hyperparathyroidism: Safe and Beneficial? Surgery. In Press.
2. Williams MD, Suliburk JW, Staerkel GA,Busaidy NL, Clayman GL, Perrier ND, Evans DB. The Cytologic Diagnosis of Follicular Lesion versus Follicular Neoplasm in Thyroid Fine Needle Aspirations: A Cinically significant Distinction when utilzed., 10/2008.
3. El-Naggar A, Sherman S, Busaidy N, Clayman G, Williams M, Santarpia L. Growth factor receptors expression in anaplastic thyroid carcinoma: Potential Markers for therapeutic stratification. J Human Pathology, 1/2008.
4. Busaidy N. Leboulleux- PETCT. JCEM, 2008.
5. Pacini, F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman SI, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Lebeoulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lasmann M, Reiners C. Radiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study. JCEM, 8/2007.
6. Stava CJ, Beck ML, Feng L, Lopez A, Busaidy NL. Diabetes mellitus among cancer survivors. Journal of Cancer Survivorship, 1/2007.
7. Mrozek E, Kloos RT, Ringel MD, Kresty L, Snider P, Arbogast D, Kies M, Munden R, Busaidy N, Klein MJ, Sherman SI, Shah MH. Phase II study of celecoxib in metastatic differentiated thyroid carcinoma. J Clin Endocrinol Metab 91(6):2201-4, 6/2006.
8. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lassmann M, Reiners C. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 91(3):926-32, 3/2006. PMID: 16384850.
9. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Jr, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R. Parathyroid carcinoma: a 22-year experience. Head Neck 26(8):716-26, 8/2004. PMID: 15287039.
10. Shepler TR, Sherman SI, Faustina MM, Busaidy NL, Ahmadi MA, Esmaeli B. Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma. Ophthal Plast Reconstr Surg 19(6):479-81, 11/2003. PMID: 14625496.
11. Baron, B, Johnson B, Lamki N, et al. The Effect of Acute IV Cocaine Challenge In Abusers on Brain Perfusion as Shown by Quantitative SPECT and Brain Perfusion Index (BPI). Journal of Nuclear Medicine 38(5):274-5, 11/1997.
12. Johnson, B, Barron B, Lamki N, et al. Brain Perfusion Abnormalities After Acute IV Cocaine Challenge in Abusers Shown by Quantitative SPECT and Brain Perfusion Index (BPI). Clinical Nuclear Medicine 22(3):199, 8/1997.
13. Lamki, N, Roberts A, Lamki L, et al. Tc-99m MAG3 Clearance by Camera Method in Renal Allografts: Its Relationship to Function at Various Periods. Clinical Nuclear Medicine 22(3):200, 8/1997.

Invited Articles
1. Busaidy NL, Jimenez C, Stava C. Endocrinologic Effects of Tyrosine Kinase Inhibitors. Hematologic Clinics of North America. In press, 2008.
Other Articles
1. Elliott, D, Busaidy NL, El Naggar A. Growth Factor Expression in Anaplastic Thyroid Carcinoma. In Manuscript., 8/2000.

Abstracts
1. Perrier ND, Edeiken B,Nunez R,Gayed I,Jimenez C, Busaidy N, Potylchansky E, Kee S,Vu T. A Novel Nomenclature to Classify Parathyroid Adenomas. World Journal of Surgery, 4/2009.
2. Brady V, Crawford K, Levesque C, Lavis V, Busady NL. Increased Insulin Requirements in Patients with Diabetes Receiving Hyper-CVA. Abstracts of the 2008 International MASCC/ISOO Symposium, 6/2008.
3. Crawford K, Levesque C, Brady V, Owens A, Busaidy N, Lavis V. Glycemic management of hospitalized patients receiving tube feeding in a cancer center. Abstract 2008 International MASCC/ISOO Symposium,, 2008.
4. Kapoor S, Cui J, Busaidy NL, Lavis V, Shah P. Hyperglycemic crises in cancer patients. American Diabetes Association, 6/2007.
5. Yazbeck CF, Gonzalez-Angulo A, Shaw SA, Waguespack SG, Vassilopoulou-Sellin R, Busaidy NL. Hypocalcemia induced by bisphosphonates in cancer patients with vitamin D deficiency. Endocrine Society, 6/2007.
6. Hu MI, Busaidy NL, Sellin RV, Waguespack SG. Non-Islet Cell Tumor Hypoglycemia and Inappropriate Cortisol Response. Endocrine Society, 6/2007.
7. Prasad A, Eng C, Shah P, Lavis V, Busaidy NL. Oncologic outcomes in diabetic patients with colon cancer. Endocrine Society, 6/2007.
8. Kapoor S, Cui J, Busaidy NL, Lavis V, Shah P. Recognized and Unrecognized Hyperglycemia in Cancer Inpatients. American Society of Clinical Oncology, 6/2007.
9. Yazbeck CF, Clayman G, Busaidy NL. Benign Thyroid goiter presents with true vocal cord paralysis. American Association of Clinical Endocrinology, 4/2007.
10. MD Williams, JW Suliburk, GA Staerkel, NL Busaidy, JE Lee, DB Evans and ND Perrier. The Incidence of Occult Papillary Thyroid Carcinomas. American Thyroid Association, 2007.
11. Fareau G, Busaidy NL. Papillary thyroid microcarcinoma with metastatic spread to bone. American Thyroid Association, 10/2006.
12. Cabanillas ME, Thomas DA, Waguespack SG, Lin E, Huang X, Palmer JL , Busaidy NL, Foudray MC, Cassat JL, Lawson A, Escalante CP , Kantarjian HM, Gagel RF. Spectrum of Hormone Abnormalities Contributing to Bone Loss in Adult Patients with Acute Lymphocytic Leukemia (ALL) and Lymphoblastic Lymphoma (LL). American Society of Bone and Mineral Research, 9/2006.
13. Geraci JM, Busaidy NL, Wang J, Lam TP, Skibber JM, Freeman JH, Goodwin JS. Hyperglycemia treatment is associated with longer length of hospital stay in colorectal, hepatic and pancreatic cancer surgery patients. American Society of Clinical Oncology, 6/2006.
14. Yazbeck CF, Shah P, Evans DB, Li D, Geraci JM, Weiser MA. Resectable pancreatic cancer patients with diabetes have shorter survival than nondiabetics. American Society of Clinical Oncology, 6/2006.
15. Cabanillas M, Thomas D., Palmer J., Mattiuzzi G., Cassat J., Foudray M., Brandt M., Lawson A., Busaidy N, Hoff A., Kantarjian H., Gagel R. . HyperCVAD Chemotherapy Causes Rapid Bone Loss in Patients with Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL). Division of Internal Medicine Retreat,, 5/2006.
16. M. Cabanillas, R. Sellin, D. Thomas, E. Bruera, G. Mattiuzzi, N. Busaidy, A. Hoff,. Hypogonadism is Common in Adult, Male Patients Receiving Frontline Chemotherpay with Hyper-CVAD for Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (ALL/LL). Division of Internal Medicine Retreat,, 5/2006.
17. Cabanillas M, Thomas D, Waguespack S, Busaidy N, Hoff A, Mattiuzzi G, Cassat J, Brandt M, Foudray M, Escalante C, Kantarjian H, Gagel R. Vitamin D Deficiency Occurs with High Frequency in Acute Leukemia. The Bone Disease Program of Texas 4th Annual Scientific Retreat, 3/2006.
18. Podoloff, DA, Stachowiak AM, Sellin RV, Busaidy NL, Habra M, Wendt RE. Therapeutic Response to High Dose (MIBG) Metaiodobenzylguanidine Therapy for Metastatic Neuroendocrine Tumors. The Society of Nuclear Medicine, 6/2005.
19. Geraci, JM, Busaidy NL, Wang J, et al. Diabetes Mellitus is Associated with Longer Length Hospital Stay in Colorectal Cancer Surgery Patients. Division of Internal Medicine Retrea, 4/2005.
20. Busaidy, NL, Habra MA, Jimenez C, Gagel RF. Diabetes Mellitus: A Possible Paraneoplastic Syndrome? Endocrine Society, 11/2004.
21. Busaidy, NL, Jimenez C, Habra MA, Gagel RF. Secondary or Tertiary Hyperparathyroidism in Tumor-Induced Osteomalacia. American Association of Clinical Endocrinologists, 11/2004.
22. Habra, MA, Busaidy NL, Jimenez C, Vassilopoulou-Sellin R. Cowden Syndrome Associated with Galactorrhea. American Association of Clinical Endocrinologists, 8/2004.
23. Jimenez, C MHabra, NBusaidy, ADekovich, RGagel, NSarlis. Portal Hypertension: Yet Another Complication of Metastatic Medullary Thyroid Carcinoma. E831C1437. International Proceedings 12th International Congress of Endocrinology. Lisbon, 8/2004.
24. Busaidy, NSHymes, CJimenez, MHabra, NSarlis. Progression of Medullary Thyroid Carcinoma Manifested as Skin Metastasis with Inflammatory Features. E831C1436. International Proceedings 12th International Congress of Endocrinology. Lisbon, 8/2004.
25. Busaidy NL, Jimenez C, Habra MA et al. Parathyroid Carcinoma. 20 Years of Experience. Abstract #102098 at American Society of Clinical Oncology,, 8/2003.
26. Aung Naing1, Patricia LoRusso2, Gordon Mills1, Don Berry1, Laurence Doyle3, Eric Rohren1, Angelika Burger2, Helen Chen3, Naifa Busaidy1, Razelle Kurzrock1. Phase I Study of combining an IGFR Inhibitor (IMC A12) and mTOR inhibitor (CCI-779) to overcome tumor resistance to mTOR inhibitors. Submitted.

Book Chapters
1. Pankaj S, Busaidy, NL, Geraci J, Hamilton M, Weiser MA. Diabetes and the Cancer Patient. In: Internal Medicine Care of Cancer. In Press.
2. Busaidy NL. Other Electrolyte / Metabolic Issues. In: In Internal Medicine Care of Cancer Patient,. In Press.
3. Busaidy NL, Kloos R. Papillary thyroid carcinoma. In: Clinical Management of Thyroid Disease. In Press.
4. M.E. Cabanillas, D.A. Thomas, S.G. Waguespack, E. Lin, X. Huang, J. L. Palmer, N.L. Busaidy, M.C. Foudray, J.L. Cassat, A. Lawson, C.P. Escalante, H.M. Kantarjian, R. Gagel. In: Spectrum of Hormone Abnormalities Contributing to Bone Loss in Adult Patients with Acute Lymphocytic Leukemia (all) and Lymphoblastic Lymphoma (LL) American Society of Bone and Mineral Research, 2006.
5. Busaidy, NL, Habra MA, Yeung SJ, Vassilopoulou-Sellin R. Endocrine Malignancies. In: Medical Oncology. McGraw-Hill, 819-854, 2006.
6. Busaidy, NL, Habra MA, Yeung SJ, Vassilopoulou-Sellin R. Endocrine Manifestations of Therapy of Nonendocrine Tumors. In: Medical Oncology. McGraw-Hill, 993-1010, 2006.
7. Busaidy NL. Management of Diabetes Mellitus. Manuscript in preparation. In: Internal Medicine Care of Cancer Patient. Internal Medicine Care of Cancer Patient, 2005.
8. Habra, MA, Busaidy NL, Vassilopoulou-Sellin R. Other Electrolyte / Metabolic Issues. Manuscript in preparation. In: Internal Medicine Care of Cancer Patient. Internal Medicine Care of Cancer Patient, 2005.

Manuals, Teaching Aids, Other Teaching Publications
1. Busaidy, NL, Busaidy KF, Yeung SJ. A 45-year old man with a Maxillary Mass and Elevated Calcium Level. Medscape, 11/2005.

Last updated: 9/18/2009